1 February 2025 false No description of principal activity Taxfiler 2024.6 10583771business:PrivateLimitedCompanyLtd2025-02-012026-01-31 105837712025-01-31 105837712025-02-012026-01-31 10583771business:AuditExempt-NoAccountantsReport2025-02-012026-01-31 10583771business:FilletedAccounts2025-02-012026-01-31 105837712026-01-31 10583771business:Director12025-02-012026-01-31 10583771business:RegisteredOffice2025-02-012026-01-31 105837712025-01-31 10583771core:WithinOneYear2026-01-31 10583771core:WithinOneYear2025-01-31 10583771core:ShareCapitalcore:PreviouslyStatedAmount2026-01-31 10583771core:ShareCapitalcore:PreviouslyStatedAmount2025-01-31 10583771core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2026-01-31 10583771core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2025-01-31 10583771core:PreviouslyStatedAmount2026-01-31 10583771core:PreviouslyStatedAmount2025-01-31 10583771business:SmallEntities2025-02-012026-01-31 10583771countries:EnglandWales2025-02-012026-01-31 10583771core:FurnitureFittings2025-02-012026-01-31 10583771core:FurnitureFittings2025-01-31 10583771core:FurnitureFittings2026-01-31 105837712024-02-012025-01-31 iso4217:GBP xbrli:pure
Company Registration No. 10583771 (England and Wales)
Asim Pharma Limited Unaudited accounts for the year ended 31 January 2026
Asim Pharma Limited Unaudited accounts Contents
Page
Company information
3
Statement of financial position
4
Notes to the accounts
5
- 2 -
Asim Pharma Limited Company Information for the year ended 31 January 2026
Director
Asim Malik
Company Number
10583771 (England and Wales)
Registered Office
6 Sandymoor Allerton Bradford West Yorkshire BD15 9LF England
Accountants
Taj Javed Ltd Chartered Certified Accountants 28 Haslingden Drive, Heaton Bradford West Yorkshire BD9 5HR
- 3 -
Asim Pharma Limited Statement of financial position as at 31 January 2026
2026 
2025 
Notes
£ 
£ 
Fixed assets
Tangible assets
4
709 
864 
Current assets
Debtors
5
3,668 
6,634 
Cash at bank and in hand
6,485 
9,671 
10,153 
16,305 
Creditors: amounts falling due within one year
6
(19,765)
(15,781)
Net current (liabilities)/assets
(9,612)
524 
Net (liabilities)/assets
(8,903)
1,388 
Capital and reserves
Called up share capital
100 
100 
Profit and loss account
(9,003)
1,288 
Shareholders' funds
(8,903)
1,388 
For the year ending 31 January 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 26 October 2026 and were signed on its behalf by
Asim Malik Director Company Registration No. 10583771
- 4 -
Asim Pharma Limited Notes to the Accounts for the year ended 31 January 2026
1
Statutory information
Asim Pharma Limited is a private company, limited by shares, registered in England and Wales, registration number 10583771. The registered office is 6 Sandymoor, Allerton, Bradford, West Yorkshire, BD15 9LF, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Fixtures & fittings
18% Reducing balance basis
4
Tangible fixed assets
Fixtures & fittings 
£ 
Cost or valuation
At cost 
At 1 February 2025
2,340 
At 31 January 2026
2,340 
Depreciation
At 1 February 2025
1,476 
Charge for the year
155 
At 31 January 2026
1,631 
Net book value
At 31 January 2026
709 
At 31 January 2025
864 
5
Debtors
2026 
2025 
£ 
£ 
Amounts falling due within one year
Trade debtors
3,448 
6,488 
Accrued income and prepayments
220 
146 
3,668 
6,634 
- 5 -
Asim Pharma Limited Notes to the Accounts for the year ended 31 January 2026
6
Creditors: amounts falling due within one year
2026 
2025 
£ 
£ 
Taxes and social security
17,444 
13,723 
Loans from directors
646 
433 
Accruals
1,675 
1,625 
19,765 
15,781 
7
Average number of employees
During the year the average number of employees was 2 (2025: 2).
- 6 -